Table 2.
SOD activity and MDA content in BXPC-3 cells 3 d after IAA and HRP treatment (mean±SD)
| Treatment | Control | 40 µmol/L | 80 µmol/L |
| IAA /HRP | IAA/HRP | ||
| SOD (nU/mg protein) | 105.60±41.04 | 135.98±1.46 | 193.34±37.89b |
| MDA (µmol/L/mg protein) | 20.80±0.33 | 22.29±1.04 | 99.53±30.45b |
bP<0.01 control group vs treatment group.